Epimed GmbH ( Site 0450)

Berlin 10787

0 studies enrolling now · 1 studies all time

What they study most

Papillomavirus Infections

Studies at this site

• Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) — Running, not enrolling